Pricing
What happens to GLP-1 self-pay offers after December 31, 2026?
Several Wegovy, Ozempic, Foundayo and Zepbound offers state December 31, 2026 end dates. Here is what each source says applies afterward, and which prices carry no stated end date.
Claims are checked against the sources cited in this article. Nothing here is individualized medical advice. How we research
On this page
Several manufacturer GLP-1 offers state an end date of December 31, 2026. In terms checked October 28, 2026, these include the $199 introductory Wegovy and Ozempic pen fills, Lilly’s temporary Foundayo price cuts, and Lilly’s Foundayo and Zepbound savings cards. Where the manufacturer’s terms say what replaces an offer, it is a listed regular or standard price: $349 for most Wegovy pens and $199 or $299 for the two Foundayo strengths, for example. Novo and Lilly hadn’t published 2027 replacement offers in the terms we read. Other prices, including Wegovy tablets and Lilly’s 45-day Journey pricing, show no end date, though both companies say they can change their programs at any time. Sources: NovoCare’s home-delivery terms, Lilly’s Foundayo terms and Lilly’s Zepbound savings terms.
This article lists dates as the manufacturers wrote them. It doesn’t predict whether an offer will be renewed. Check the manufacturer’s page again before any purchase in 2027.
Offers with a stated December 31, 2026 end date
| Offer | What the terms say about the end date | What the terms say applies afterward |
|---|---|---|
| Wegovy pen introductory price, NovoCare home delivery ($199 per fill of 0.25 or 0.5 mg, first two 28-day fills, new patients) | Prescription written on or before December 31, 2026, received by the pharmacy by the end of that day, and shipped by January 31, 2027 | Third fill at the standard price: $349 (0.25–2.4 mg) or $399 (HD 7.2 mg) |
| Wegovy pen introductory price, retail savings offer | Offer redeemed and prescription filled by December 31, 2026 | Third fill at the standard price |
| Ozempic pen introductory price, NovoCare home delivery ($199, same structure) | Same written/received/shipped dates as Wegovy | Standard price: $349 (0.25, 0.5 or 1 mg) or $499 (2 mg) |
| Wegovy coupon on TrumpRx | “Only available for 2 monthly fills between 11/17/2025–12/31/2026” | $349 a month, or $399 for HD 7.2 mg |
| Foundayo 2.5 mg and 5.5 mg temporary prices ($149 and $199) | Reduced “through December 31, 2026” | Regular prices: $199 (2.5 mg) and $299 (5.5 mg) |
| Foundayo Self-Pay Savings Card and Foundayo commercial Savings Card | “Card expires and savings end on 12/31/2026” | No replacement card is described |
| Zepbound KwikPen Self-Pay Savings Card | “Card expires and savings end on 12/31/2026” | No replacement card is described |
| Zepbound single-dose pen and KwikPen commercial Savings Card ($25 for covered pens, with limits) | “Card expires and savings end on 12/31/2026” | No replacement card is described |
Additional sources: Novo’s retail savings-offer terms, the TrumpRx Wegovy listing and Lilly’s KwikPen self-pay terms. The strengths identify the products the offers apply to. They are not dosing guidance.
The two Wegovy introductory channels word their deadlines differently. Home delivery allows shipping through January 31, 2027 for a prescription received by December 31. The retail offer requires the fill itself by December 31. If you’re counting on the introductory price, find out which channel you’re using. Don’t change a prescription or the timing of a fill to chase a deadline without talking to your clinician.
Lilly’s post-purchase claim deadline is March 31, 2027
Lilly’s Foundayo and Zepbound KwikPen self-pay card terms allow a claim afterward if Lilly couldn’t confirm at checkout that a refill was made within the required 45 days. Those claims must be submitted or postmarked by March 31, 2027. Keep your pharmacy receipts and delivery dates from 2026 purchases until you’re sure no claim is needed.
Prices with no stated end date
Some prices on the same pages show no end date. The terms say these offers can still be changed, withdrawn or amended at any time, so “no stated end date” doesn’t guarantee they’ll continue.
- Wegovy tablets: $149 (1.5 mg), $199 (4 mg) and $299 (9 or 25 mg) per 30-tablet bottle. Ozempic tablets: $149, $199 or $299 per bottle at 1.5, 4 or 9 mg. Novo’s footnotes give no end date for either.
- Standard Wegovy and Ozempic pen prices: the same prices the introductory offers switch to.
- Novo’s $25 commercial savings offer for covered patients: the terms we read give no end date. Savings are capped at $100 a month, and government beneficiaries are excluded.
- Zepbound Self Pay Journey offer: $449 for 7.5–15 mg vials or KwikPens, which started February 23, 2026 and requires each refill within 45 days. The Journey terms give no end date. LillyDirect says it applies savings automatically, but the separate KwikPen self-pay card used at other pharmacies expires December 31, 2026. What KwikPen buyers outside LillyDirect will pay in January isn’t stated in the terms we read, so ask LillyDirect or your pharmacy.
- Foundayo Journey offer: $299 for 14.5 or 17.2 mg with refills within 45 days. No end date is given in the purchase-offer section. The self-pay card section that also lists it expires December 31, 2026.
Our cost guides for Wegovy, Ozempic, Zepbound and Foundayo have the full price tables.
January 1, 2027 changes that don’t touch cash prices
Novo announced on February 24, 2026 that it will lower the list price of Wegovy, Ozempic and Rybelsus to $675 a month on January 1, 2027. It said the change does “not have an impact on direct-to-patient, self-pay prices” (Novo’s announcement). The list price can affect insured patients whose costs are based on it, through a deductible or coinsurance. Ask your plan whether it changes your share of the cost.
Medicare’s temporary GLP-1 Bridge isn’t a self-pay offer, and it doesn’t end on December 31, 2026. Medicare’s page says an approved prior authorization stays valid through December 31, 2027 unless you change GLP-1s. Our Medicare guide covers eligibility.
What to do before and after the deadline
- List the offers you use now. Write down the product, strength, price and whether it’s introductory, temporary, card-based or refill-conditioned.
- Check the stated end date and the price that follows. Use the table above as a starting point, then confirm on the manufacturer’s page.
- Ask for a written January quote. Your pharmacy or the manufacturer’s pharmacy can tell you which price it expects to charge for your first 2027 fill.
- Recheck in January. Manufacturers can publish new terms at any time. A 2027 offer, if one appears, will have its own conditions.
- Keep care fees separate. A telehealth membership has its own renewal terms. A medicine offer ending doesn’t change it, and a care plan continuing doesn’t extend a medicine offer.
If the price that follows an offer changes your plans, talk to your clinician before making any treatment change. Our savings card guide explains how each card works while it’s active.